ILOPROST concentrate solution for infusion

ILOPROST concentrate solution for infusion
Product Description

Strength: 20 mcg/ml; 100 mcg/ml Presentation: ampoules, 0.5 ml (100 mcg/ml); 1 ml (20 mcg/ml & 100 mcg/ml); 2.5 ml (20 mcg/ml) Therapeutic area: Severe peripheral arterial occlusive disease (PAOD) Innovator: Ilomedin (Bayer)

Rafarm S.A

  • Country/Region:
    Greece
  • On CPHI since:
    2015

Rafarm S.A

  • Country/Region:
    Greece
  • On CPHI since:
    2015

More Products from Rafarm S.A (38)